Ameritas Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Ameritas Advisory Services's REGN Position: Q2 2026 in Review
Ameritas Advisory Services opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 119 shares worth $74.3K. The stake represents ﹤0.01% of the portfolio and ranks #1202 among its holdings. This is a return to the name: Ameritas Advisory Services previously reported a position in REGN as recently as Q3 2025.
Ameritas Advisory Services first reported a position in REGN in Q4 2021 and has held it in 13 quarters since. The position peaked at $400K in Q2 2024. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Ameritas Advisory Services held 119 shares of Regeneron Pharmaceuticals worth $74.3K as of Q2 2026.
- Regeneron Pharmaceuticals was a new Ameritas Advisory Services position in Q2 2026.
- Regeneron Pharmaceuticals made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1202 holding.
- Ameritas Advisory Services first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 13 quarters since.
- Ameritas Advisory Services's Regeneron Pharmaceuticals position peaked at $400K in Q2 2024.
- 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.